Tags

Type your tag names separated by a space and hit enter

Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study.
Hypertens Res 2014; 37(10):950-3HR

Abstract

Antihypertensive drugs have been linked to new-onset atrial fibrillation (NAF); however, the way in which these drugs affect the development of NAF in hypertensive patients has not been thoroughly examined. Herein, we report a population-based study in which we investigated the relationship between antihypertensive drug therapy and the risk of NAF. The population sample consisted of 47 682 hypertensive patients identified from claim forms provided to the central regional branch of the Bureau of National Health Insurance in Taiwan between January 2005 and December 2010. Prescriptions for antihypertensive drugs prescribed before the index date were retrieved from a prescription database. From these data, we estimated the hazard ratio (HR) of NAF associated with antihypertensive drug use; non-NAF subjects served as the reference group. After adjusting for age and sex, we observed that the risk of NAF was higher among the patients taking diuretics (HR, 1.39; 95% confidence interval (CI), 1.06-1.82) compared with the patients not taking diuretics. Patients who took angiotensin-converting enzyme (ACE) inhibitors (HR, 0.79; 95% CI, 0.65-0.97) showed a lower risk of developing NAF compared with the nonusers of ACE inhibitors. Angiotensin receptor blockers, alpha-blockers, beta-blockers and calcium channel blockers were not associated with a risk of NAF. The results of this study suggest that hypertensive patients who take diuretics have a significant increase in the risk of NAF, whereas patients who take ACE inhibitors are at lower risk of NAF.

Authors+Show Affiliations

1] Department of Internal Medicine, Chung Shan Medical University Hospital and Chung Shan Medical University, Taichung, Taiwan, ROC [2] Department of Basic Science, Central Taiwan University of Science and Technology, Taichung, Taiwan, ROC.Institute of Pharmacy, China Medical University, Taichung, Taiwan, ROC.Department of Nursing, Lin Shin Hospital, Taichung, Taiwan, ROC.1] Department of Family Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC [2] Department of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24965171

Citation

Jong, Gwo-Ping, et al. "Long-term Effect of Antihypertensive Drugs On the Risk of New-onset Atrial Fibrillation: a Longitudinal Cohort Study." Hypertension Research : Official Journal of the Japanese Society of Hypertension, vol. 37, no. 10, 2014, pp. 950-3.
Jong GP, Chen HY, Li SY, et al. Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study. Hypertens Res. 2014;37(10):950-3.
Jong, G. P., Chen, H. Y., Li, S. Y., & Liou, Y. S. (2014). Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study. Hypertension Research : Official Journal of the Japanese Society of Hypertension, 37(10), pp. 950-3. doi:10.1038/hr.2014.104.
Jong GP, et al. Long-term Effect of Antihypertensive Drugs On the Risk of New-onset Atrial Fibrillation: a Longitudinal Cohort Study. Hypertens Res. 2014;37(10):950-3. PubMed PMID: 24965171.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study. AU - Jong,Gwo-Ping, AU - Chen,Hung-Yi, AU - Li,Shu-Yi, AU - Liou,Yi-sheng, Y1 - 2014/06/26/ PY - 2013/12/06/received PY - 2014/04/14/revised PY - 2014/04/16/accepted PY - 2014/6/27/entrez PY - 2014/6/27/pubmed PY - 2015/6/16/medline SP - 950 EP - 3 JF - Hypertension research : official journal of the Japanese Society of Hypertension JO - Hypertens. Res. VL - 37 IS - 10 N2 - Antihypertensive drugs have been linked to new-onset atrial fibrillation (NAF); however, the way in which these drugs affect the development of NAF in hypertensive patients has not been thoroughly examined. Herein, we report a population-based study in which we investigated the relationship between antihypertensive drug therapy and the risk of NAF. The population sample consisted of 47 682 hypertensive patients identified from claim forms provided to the central regional branch of the Bureau of National Health Insurance in Taiwan between January 2005 and December 2010. Prescriptions for antihypertensive drugs prescribed before the index date were retrieved from a prescription database. From these data, we estimated the hazard ratio (HR) of NAF associated with antihypertensive drug use; non-NAF subjects served as the reference group. After adjusting for age and sex, we observed that the risk of NAF was higher among the patients taking diuretics (HR, 1.39; 95% confidence interval (CI), 1.06-1.82) compared with the patients not taking diuretics. Patients who took angiotensin-converting enzyme (ACE) inhibitors (HR, 0.79; 95% CI, 0.65-0.97) showed a lower risk of developing NAF compared with the nonusers of ACE inhibitors. Angiotensin receptor blockers, alpha-blockers, beta-blockers and calcium channel blockers were not associated with a risk of NAF. The results of this study suggest that hypertensive patients who take diuretics have a significant increase in the risk of NAF, whereas patients who take ACE inhibitors are at lower risk of NAF. SN - 1348-4214 UR - https://www.unboundmedicine.com/medline/citation/24965171/Long_term_effect_of_antihypertensive_drugs_on_the_risk_of_new_onset_atrial_fibrillation:_a_longitudinal_cohort_study_ L2 - http://dx.doi.org/10.1038/hr.2014.104 DB - PRIME DP - Unbound Medicine ER -